QLT PhotoTherapeutics Inc., American Home Products deal

QLTIF reacquired Italian marketing rights for its Photofrin light-activated cancer drug from AHP's American Cyanamid Co. subsidiary. QLTIF, which did not pay to regain the rights, is moving to centralize marketing in Europe with a new partner. Photofrin (porfimer sodium) is approved in France and the Netherlands to treat certain lung and esophageal cancers, and is under review in five other European countries, including Italy. ...